Abstract
Cardiovascular disease (CVD) and chronic kidney disease (CKD) constitute substantial burdens for public health. The identification and validation of risk markers for CVD and CKD in epidemiological studies requires frequent adaption of existing analytical methods as well as development of new methods. In this study, an analytical procedure to simultaneously quantify ten endogenous biomarkers for CVD and CKD is described. An easy-to-handle sample preparation requiring only 20 µL of human plasma is followed by liquid chromatography coupled to tandem mass spectrometry (LC–MS/MS). The method was successfully validated according to established guidelines meeting required criteria for accuracy, precision, recovery, linearity, selectivity, and limits of quantification. The scalability of the method for application in larger cohorts was assessed using a set of plasma samples from healthy volunteers (n = 391) providing first reference values for the recently established biomarker Nɛ-acetyllysine (Nɛ-AcLys). Other biomarkers analyzed were creatinine, β-aminoisobutyric acid (β-AIB), carnitine, 1-methylnicotinamide (1-MNA), citrulline, symmetric dimethylarginine (SDMA), asymmetric dimethylarginine (ADMA), homoarginine (hArg), and ornithine. All obtained results are within reference values specified elsewhere. Overall, these results demonstrate the suitability of the method for simultaneous quantification of ten endogenous biomarkers for CVD and CKD in plasma samples from larger cohorts and allow validation of Nɛ-AcLys as a biomarker in large cohorts.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alrob OA, Sankaralingam S, Ma C, Wagg CS, Fillmore N, Jaswal JS, Sack MN, Lehner R, Gupta MP, Michelakis ED, Padwal RS, Johnstone DE, Sharma AM, Lopaschuk GD (2014) Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling. Cardiovasc Res 103:485–497. https://doi.org/10.1093/cvr/cvu156
Atzler D, Mieth M, Maas R, Böger RH, Schwedhelm E (2011) Stable isotope dilution assay for liquid chromatography-tandem mass spectrometric determination of l-homoarginine in human plasma. J Chromatogr B Anal Technol Biomed Life Sci 879:2294–2298. https://doi.org/10.1016/j.jchromb.2011.06.016
Böger RH, Sullivan LM, Schwedhelm E, Wang TJ, Maas R, Benjamin EJ, Schulze F, Xanthakis V, Benndorf RA, Vasan RS (2009) Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation 119:1592–1600. https://doi.org/10.1161/CIRCULATIONAHA.108.838268
Fukushima A, Lopaschuk GD (2016) Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure. Biochim Biophys Acta 1862:2211–2220. https://doi.org/10.1016/j.bbadis.2016.07.020
Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Lambers Heerspink HJ, Mann JF, Matsushita K, Wen CP (2013) Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 382:339–352. https://doi.org/10.1016/S0140-6736(13)60595-4
Gil J, Ramirez-Torres A, Encarnacion-Guevara S (2017) Lysine acetylation and cancer: a proteomics perspective. J Proteom 150:297–309. https://doi.org/10.1016/j.jprot.2016.10.003
Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, Hobbs FD (2016) Global prevalence of chronic kidney disease—a systematic review and meta-analysis. PLoS One 11:e0158765. https://doi.org/10.1371/journal.pone.0158765
Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, Grueter CA, Harris C, Biddinger S, Ilkayeva OR, Stevens RD, Li Y, Saha AK, Ruderman NB, Bain JR, Newgard CB, Farese RV Jr, Alt FW, Kahn CR, Verdin E (2010) SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464:121–125. https://doi.org/10.1038/nature08778
Hirschey MD, Shimazu T, Jing E, Grueter CA, Collins AM, Aouizerat B, Stančáková A, Goetzman E, Lam MM, Schwer B, Stevens RD, Muehlbauer MJ, Kakar S, Bass NM, Kuusisto J, Laakso M, Alt FW, Newgard CB, Farese RV Jr, Kahn CR, Verdin E (2011) SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell 44:177–190. https://doi.org/10.1016/j.molcel.2011.07.019
Horton JL, Martin OJ, Lai L, Riley NM, Richards AL, Vega RB, Leone TC, Pagliarini DJ, Muoio DM, Bedi KC Jr, Margulies KB, Coon JJ, Kelly DP (2016) Mitochondrial protein hyperacetylation in the failing heart. JCI Insight 2:e84897. https://doi.org/10.1172/jci.insight.84897
Hyndman KA, Knepper MA (2017) Dynamic regulation of lysine acetylation: the balance between acetyltransferase and deacetylase activities. Am J Physiol Renal Physiol 313:F842–F846. https://doi.org/10.1152/ajprenal.00313.2017
Ito S, Kusuhara H, Kumagai Y, Moriyama Y, Inoue K, Kondo T, Nakayama H, Horita S, Tanabe K, Yuasa H, Sugiyama Y (2012) N-methylnicotinamide is an endogenous probe for evaluation of drug-drug interactions involving multidrug and toxin extrusions (MATE1 and MATE2-K). Clin Pharmacol Ther 92:635–641. https://doi.org/10.1038/clpt.2012.138
Jing E, O’Neill BT, Rardin MJ, Kleinridders A, Ilkeyeva OR, Ussar S, Bain JR, Lee KY, Verdin EM, Newgard CB, Gibson BW, Kahn CR (2013) Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation. Diabetes 62:3404–3417. https://doi.org/10.2337/db12-1650
Jud P, Hafner F, Verheyen N, Meinitzer A, Gary T, Brodmann M, Seinost G, Hackl G (2018) Homoarginine/ADMA ratio and homoarginine/SDMA ratio as independent predictors of cardiovascular mortality and cardiovascular events in lower extremity arterial disease. Sci Rep 8:14197. https://doi.org/10.1038/s41598-018-32607-8
Kayacelebi AA, Minovic I, Hanff E, Frenay AS, de Borst MH, Feelisch M, van Goor H, Bakker SJL, Tsikas D (2017) Low plasma homoarginine concentration is associated with high rates of all-cause mortality in renal transplant recipients. Amino Acids 49:1193–1202. https://doi.org/10.1007/s00726-017-2420-7
Kielstein JT, Salpeter SR, Bode-Boeger SM, Cooke JP, Fliser D (2006) Symmetric dimethylarginine (SDMA) as endogenous marker of renal function—a meta-analysis. Nephrol Dial Transplant 21:2446–2451. https://doi.org/10.1093/ndt/gfl292
Kittel A, Maas R, König J, Mieth M, Weiss N, Jarzebska N, Hohenstein B, Martens-Lobenhoffer J, Bode-Böger SM, Rodionov RN (2013) In vivo evidence that Agxt2 can regulate plasma levels of dimethylarginines in mice. Biochem Biophys Res Commun 430:84–89. https://doi.org/10.1016/j.bbrc.2012.11.008
Kittel A, Müller F, König J, Mieth M, Sticht H, Zolk O, Kralj A, Heinrich MR, Fromm MF, Maas R (2014) Alanine-glyoxylate aminotransferase 2 (AGXT2) polymorphisms have considerable impact on methylarginine and β-aminoisobutyrate metabolism in healthy volunteers. PLoS One 9:e88544. https://doi.org/10.1371/journal.pone.0088544
Kurylowicz A (2016) In search of new therapeutic targets in obesity treatment: sirtuins. Int J Mol Sci 17:572. https://doi.org/10.3390/ijms17040572
Levey AS, Inker LA (2017) Assessment of glomerular filtration rate in health and disease: a state of the art review. Clin Pharmacol Ther 102:405–419. https://doi.org/10.1002/cpt.729
Liu M, Chu J, Gu Y, Shi H, Zhang R, Wang L, Chen J, Shen L, Yu P, Chen X, Ju W, Wang Z (2017) Serum N 1-methylnicotinamide is associated with coronary artery disease in chinese patients. J Am Heart Assoc 6:e004328. https://doi.org/10.1161/JAHA.116.004328
Liu M, He A, Chu J, Chen C, Zhang S, He Y, Tao W, Lu M, Hua M, Ju W, Fang Z (2018) Serum N 1-methylnicotinamide is associated with left ventricular systolic dysfunction in chinese. Sci Rep 8:8581. https://doi.org/10.1038/s41598-018-26956-7
Martens-Lobenhoffer J, Bode-Böger SM (2014) Mass spectrometric quantification of l-arginine and its pathway related substances in biofluids: the road to maturity. J Chromatogr B Anal Technol Biomed Life Sci 964:89–102. https://doi.org/10.1016/j.jchromb.2013.10.030
Meinitzer A, Kielstein JT, Pilz S, Drechsler C, Ritz E, Boehm BO, Winkelmann BR, März W (2011) Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem 57:112–121. https://doi.org/10.1373/clinchem.2010.150854
Müller F, Pontones CA, Renner B, Mieth M, Hoier E, Auge D, Maas R, Zolk O, Fromm MF (2015) N 1-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction. Eur J Clin Pharmacol 71:85–94. https://doi.org/10.1007/s00228-014-1770-2
Nigam SK (2018) The SLC22 transporter family: a paradigm for the impact of drug transporters on metabolic pathways, signaling, and disease. Annu Rev Pharmacol Toxicol 58:663–687. https://doi.org/10.1146/annurev-pharmtox-010617-052713
Ogawa T, Kimoto M, Sasaoka K (1989) Purification and properties of a new enzyme, NG, NG-dimethylarginine dimethylaminohydrolase, from rat kidney. J Biol Chem 264:10205–10209
Pilz S, Meinitzer A, Tomaschitz A, Drechsler C, Ritz E, Krane V, Wanner C, Boehm BO, März W (2011) Low homoarginine concentration is a novel risk factor for heart disease. Heart 97:1222–1227. https://doi.org/10.1136/hrt.2010.220731
Pilz S, Meinitzer A, Gaksch M, Grübler M, Verheyen N, Drechsler C, Hartaigh BÓ, Lang F, Alesutan I, Voelkl J, März W, Tomaschitz A (2015) Homoarginine in the renal and cardiovascular systems. Amino Acids 47:1703–1713. https://doi.org/10.1007/s00726-015-1993-2
Rodionov RN, Murry DJ, Vaulman SF, Stevens JW, Lentz SR (2010) Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production. J Biol Chem 285:5385–5391. https://doi.org/10.1074/jbc.M109.091280
Roth GA, Huffman MD, Moran AE, Feigin V, Mensah GA, Naghavi M, Murray CJ (2015) Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation 132:1667–1678. https://doi.org/10.1161/CIRCULATIONAHA.114.008720
Schlesinger S, Sonntag SR, Lieb W, Maas R (2016) Asymmetric and symmetric dimethylarginine as risk markers for total mortality and cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. PLoS One 11:e0165811. https://doi.org/10.1371/journal.pone.0165811
Schwedhelm E, Xanthakis V, Maas R, Sullivan LM, Schulze F, Riederer U, Benndorf RA, Böger RH, Vasan RS (2009) Asymmetric dimethylarginine reference intervals determined with liquid chromatography-tandem mass spectrometry: results from the Framingham offspring cohort. Clin Chem 55:1539–1545. https://doi.org/10.1373/clinchem.2009.124263
Schwedhelm E, Xanthakis V, Maas R, Sullivan LM, Atzler D, Lüneburg N, Glazer NL, Riederer U, Vasan RS, Böger RH (2011) Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort. Clin Chem Lab Med 49:1907–1910. https://doi.org/10.1515/CCLM.2011.679
Tain YL, Hsu CN (2017) Toxic dimethylarginines: asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA). Toxins (Basel) 9:92. https://doi.org/10.3390/toxins9030092
Taylor PJ (2005) Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem 38:328–334. https://doi.org/10.1016/j.clinbiochem.2004.11.007
Tsikas D, Wu G (2015) Homoarginine, arginine, and relatives: analysis, metabolism, transport, physiology, and pathology. Amino Acids 47:1697–1702. https://doi.org/10.1007/s00726-015-2055-5
Tsuda M, Fukushima A, Matsumoto J, Takada S, Kakutani N, Nambu H, Yamanashi K, Furihata T, Yokota T, Okita K, Kinugawa S, Anzai T (2018) Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure. J Cachexia Sarcopenia Muscle 9:844–859. https://doi.org/10.1002/jcsm.12322
US Department of Health and Human Services (2018) FDA Bioanalytical Method Validation, Guidance for Industry. https://www.fda.gov/downloads/drugs/guidances/ucm070107.pdf. Accessed 29 Jan 2019
Vallance P, Leone A, Calver A, Collier J, Moncada S (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572–575
Vazquez EJ, Berthiaume JM, Kamath V, Achike O, Buchanan E, Montano MM, Chandler MP, Miyagi M, Rosca MG (2015) Mitochondrial complex I defect and increased fatty acid oxidation enhance protein lysine acetylation in the diabetic heart. Cardiovasc Res 107:453–465. https://doi.org/10.1093/cvr/cvv183
Wagner GR, Payne RM (2013) Widespread and enzyme-independent N ɛ-acetylation and N ɛ-succinylation of proteins in the chemical conditions of the mitochondrial matrix. J Biol Chem 288:29036–29045. https://doi.org/10.1074/jbc.M113.486753
Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, Vazquez-Fresno R, Sajed T, Johnson D, Li C, Karu N, Sayeeda Z, Lo E, Assempour N, Berjanskii M, Singhal S, Arndt D, Liang Y, Badran H, Grant J, Serra-Cayuela A, Liu Y, Mandal R, Neveu V, Pon A, Knox C, Wilson M, Manach C, Scalbert A (2018) HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res 46:D608–D617. https://doi.org/10.1093/nar/gkx1089
Zhao S, Xu W, Jiang W, Yu W, Lin Y, Zhang T, Yao J, Zhou L, Zeng Y, Li H, Li Y, Shi J, An W, Hancock SM, He F, Qin L, Chin J, Yang P, Chen X, Lei Q, Xiong Y, Guan KL (2010) Regulation of cellular metabolism by protein lysine acetylation. Science 327:1000–1004. https://doi.org/10.1126/science.1179689
Zinellu A, Paliogiannis P, Carru C, Mangoni AA (2018) Homoarginine and all-cause mortality: a systematic review and meta-analysis. Eur J Clin Invest 48:e12960. https://doi.org/10.1111/eci.12960
Zoccali C, Bode-Böger SM, Mallamaci F, Benedetto FA, Tripepi G, Malatino LS, Cataliotti A, Bellanuova I, Fermo I, Frölich JC, Böger RH (2001) Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358:2113–2117
Acknowledgements
This work was supported by the STAEDTLER foundation (grant 34/14).
Author information
Authors and Affiliations
Contributions
AG, MM, DA, AC, FM, MFF, and RM designed research, performed research, and analyzed data. AG, MM, MFF, and RM wrote the manuscript. All authors reviewed and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
FM is an employee of Boehringer Ingelheim. The other authors declare that they have no conflict of interest.
Research involving human participants and/or animals
This study involved human participants. It was approved by the Ethics committee of the Friedrich-Alexander-Universität Erlangen-Nürnberg and conducted according to the Declaration of Helsinki.
Informed consent
All participants provided written informed consent.
Additional information
Handling Editor: D. Tsikas.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gessner, A., Mieth, M., Auge, D. et al. Establishment of reference values for the lysine acetylation marker Nɛ-acetyllysine in small volume human plasma samples by a multi-target LC–MS/MS method. Amino Acids 51, 1259–1271 (2019). https://doi.org/10.1007/s00726-019-02765-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-019-02765-8